Publications by authors named "Max Grogl"

Claim this Profile
S
Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers.
Oussama Mouri, Cléa Melenotte, Romain Guéry, Camille Cotteret, Arnaud Schweitzer-Chaput, Max Grogl

PLoS Negl Trop Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a diagnostic device, CL Detect rapid test for the diagnosis of new world cutaneous leishmaniasis in Peru.
Max Grogl, Christie A Joya, Maria Saenz, Ana Quispe, Luis Angel Rosales

PLoS Negl Trop Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial.
Alejandro Llanos-Cuentas, Alvaro Schwalb, Juan Luis Quintana, Brian Delfin, Fiorela Alvarez, Max Grogl

BMC Res Notes· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Whole-Virus COVID-19 Vaccine among Healthcare Personnel, Lima, Peru.
Carmen S Arriola, Giselle Soto, Matthew Westercamp, Susan Bollinger, Angelica Espinoza, Max Grogl

Emerg Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evaluation of the BioFire Global Fever Panel for the identification of malaria, leptospirosis, chikungunya, and dengue from whole blood: a prospective, multicentre, cross-sectional diagnostic accuracy study.
Yukari C Manabe, Joshua Betz, Olivia Jackson, Victor Asoala, Isabel Bazan, Max Grogl

Lancet Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guillain-Barré Syndrome Outbreak in Peru 2019 Associated With Infection.
Ana P Ramos, Sonja E Leonhard, Susan K Halstead, Mireya A Cuba, Carlos C Castañeda, Max Grogl

Neurol Neuroimmunol Neuroinflamm· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Identification of Parasites Causing Cutaneous Leishmaniasis in Panama.
Aracelis Del C Miranda, Kadir A González, Franklyn Samudio, Vanessa J Pineda, José E Calzada

Am J Trop Med Hyg· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical paromomycin for New World cutaneous leishmaniasis.
Néstor Sosa, Juan Miguel Pascale, Ana I Jiménez, Jeanne A Norwood, Mara Kreishman-Detrick, Max Grogl

PLoS Negl Trop Dis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation.
Piero Olliaro, Max Grogl, Marina Boni, Edgar M Carvalho, Houda Chebli

PLoS Negl Trop Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered Screening Paradigm for Development of Drugs To Treat Cutaneous Leishmaniasis.
Diana Caridha, Sandi Parriot, Thomas H Hudson, Thierry Lang, Franklyn Ngundam, Max Grogl

Antimicrob Agents Chemother· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating to Zero: Strategies to Eliminate Malaria in the Peruvian Amazon.
Antonio M Quispe, Alejandro Llanos-Cuentas, Hugo Rodriguez, Martin Clendenes, Cesar Cabezas, Max Grogl

Am J Trop Med Hyg· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antileishmanial Activity of Compounds Derived from the Medicines for Malaria Venture Open Access Box Against Intracellular Leishmania major Amastigotes.
Mozna Khraiwesh, Susan Leed, Norma Roncal, Jacob Johnson, Richard Sciotti, Max Grogl

Am J Trop Med Hyg· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct comparison of the efficacy and safety of oral treatments with oleylphosphocholine (OlPC) and miltefosine in a mouse model of L. major cutaneous leishmaniasis.
Anny Fortin, Diana P Caridha, Susan Leed, Franklyn Ngundam, Jenell Sena, Max Grogl

PLoS Negl Trop Dis· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In response.
Max Grogl, Nestor Sosa, Mara Kreishman-Deitrick

Am J Trop Med Hyg· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parasite load decrease during application of a safe and easily applied antileishmanial aminoglycoside cream.
Afif Ben Salah, Amor Zaâtour, Nathalie Ben Messaoud, Abdelhamid Kidar, Philip L Smith, Max Grogl

PLoS Negl Trop Dis· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activity.
Elizabeth R Sharlow, Stephanie Leimgruber, Samantha Murray, Ana Lira, Richard J Sciotti

ACS Chem Biol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and absorption of paromomycin and gentamicin from topical creams used to treat cutaneous leishmaniasis.
William R Ravis, Alejandro Llanos-Cuentas, Nestor Sosa, Mara Kreishman-Deitrick, Karen M Kopydlowski, Max Grogl

Antimicrob Agents Chemother· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama.
Néstor Sosa, Zeuz Capitán, Javier Nieto, Melissa Nieto, José Calzada, Max Grogl

Am J Trop Med Hyg· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis.
Piero Olliaro, Michel Vaillant, Byron Arana, Max Grogl, Farrokh Modabber

PLoS Negl Trop Dis· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contributions of the Global Emerging Infections Surveillance and Response System Network to global health security in 2011.
David L Blazes, Jennifer L Bondarenko, Ronald L Burke, Kelly G Vest, Mark M Fukuda, Max Grogl

US Army Med Dep J· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An in vivo drug screening model using glucose-6-phosphate dehydrogenase deficient mice to predict the hemolytic toxicity of 8-aminoquinolines.
Peng Zhang, Xiugong Gao, Hiroshi Ishida, Jack Amnuaysirikul, Peter J Weina, Max Grogl

Am J Trop Med Hyg· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
Afif Ben Salah, Nathalie Ben Messaoud, Evelyn Guedri, Amor Zaatour, Nissaf Ben Alaya, Max Grogl

N Engl J Med· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug discovery algorithm for cutaneous leishmaniasis.
Max Grogl, Mark Hickman, William Ellis, Thomas Hudson, John S Lazo

Am J Trop Med Hyg· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capacity-building efforts by the AFHSC-GEIS program.
Jose L Sanchez, Matthew C Johns, Ronald L Burke, Kelly G Vest, Mark M Fukuda, Max Grogl

BMC Public Health· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-leishmanial drug discovery: rising to the challenges of a highly neglected disease.
Elizabeth R Sharlow, Max Grögl, Jacob Johnson, John S Lazo

Mol Interv· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis